Expanding horizons of intranasal care

Who We Are

Polyrizon is a biotech company, focused on the development and commercialization of innovative intranasal products.

Play Video

Platform Technologies

Capture & Contain ™ (C&C)

ON A MISSION TO PROTECT PATIENTS. DIFFERENTLY.

Trap & Target ™ (T&T)

New horizons for intranasal drug delivery

Our Team

Management

TOMER IZRAELI

B.Sc, MBA – FOUNDER & CEO

Conceived technology idea, initial research toward development.
Over 18 years of medical device and pharmaceutical development, sales and BD management

TOMER IZRAELI

FOUNDER & CHIEF
EXECUTIVE OFFICER

Nir Ben Yosef

Nir Ben Yosef -CFO

CPA, B.A

Mr. Ben Yosef has served as the Chief Financial Officer of ENvizion Medical Ltd.(TASE:ENVM.TA) Since the beginning of 2021 till October 2021 and he is a partner in Shimony Yosef Certified Public Accountant (Isr.) since 2011.

Nir Ben Yosef

CHIEF FINANCIAL
OFFICER

Daphna Avital

MA – CPO

Organizational Consulting and certified Group Facilitator, with over 20 years' experience in   Senior Management positions in global pharmaceutical companies such as Allergen and AstraZeneca.

Daphna Avital

CHIEF PEOPLE
OFFICER

Eyal S. Ron

Ph.D – CTO

Highly experienced drug & biomaterials development.
Founded/co-founded of 9 companies. Held position at the Harvard-MIT Division of Health Sciences & Technology.

DR. EYAL S. RON

CHIEF TECHNOLOGY
OFFICER

DR. TIDHAR TURGEMAN

Ph.D – CRO

Strong background in small synthetic molecules, and drug delivery systems. Creative R&D   expert, experience evaluating and leading the development of innovative technologies.

DR. TIDHAR TURGEMAN

CHIEF R&D
OFFICER

Scientific Advisory Board

Prof. Avi Schroeder

Avi Schroeder is an associate professor and a member of the Wolfson Faculty of Chemical Engineering at the Technion. He leads the Laboratory for Targeted Drug Delivery & Personalized Medicine Technologies

Prof. Avi Schroeder

Prof. Smadar Cohen

World renown delivery systems & formulations expert. Head of the department of biotechnology engineering at Ben Gurion University, Israel.

Prof. Smadar Cohen

Prof. Fabio Sonvico

Associate professor at the department of pharmacy of the University of Parma, Italy. Highly experience in the development of intranasal and pulmonary routes and products.

Prof. Fabio Sonvico

Prof. Nancy Agmon-Levin

Head of the Clinical Immunology, Angioedema and Allergy Unit, Lupus and Autoimmune Diseases Clinic of Sheba medical Center, Israel. Expert in Immunology and Allergy.

Prof. Nancy Agmon-Levin

Board of Directors

TOMER IZRAELI

B.Sc, MBA – FOUNDER & CEO DIRECTOR

Mr. Tomer Izraeli has served as our Chief Executive Officer and a member of our board of directors since March 2020 and also served as our chief executive officer and director from 2005 to 2013. Mr. Izraeli also served as Department Manager in Lapidot Medical Ltd. Mr. Izraeli has served as a director in LMF Medical Ltd. since 2023. Mr. Izraeli has a BSc in chemical engineering and an MBA from the Ben Gurion University of the Negev.

Tomer Izraeli

Asaf Itzhaik

 Director

Mr. Itzhaik is a seasoned international businessman in retail, BTC, BTB and real estate. He has served as a director of the Company since May 2024. He has served as a director in Clearmind Ltd (NASDAQ) since 2022, GIX Internet (Israel) since 2021, Save Foods Ltd. (Nasdaq) since 2024, Rani Zim (Israel) since 2022 and Plentify Ltd. (Canadian SE) since 2023. He has 28 years of experience running an optic brand specializing in athletes.

Asaf Itzhaik

Omer Srugo

Director

Mr. Srugo currently serves as the Head of Debt at Electra Real Estate Ltd., where he manages debt funds totaling $620 million, focusing on multi-family home properties across the Southeastern region of the United States. Prior to that, between 2021 to 2024, Mr. Srugo was a Senior Financial Advisor at Somekh Chaikin, a member firm of KPMG, where he led teams in financial due diligence and transaction support in various industries, including biotech, hi-tech and real estate. Mr. Srugo holds a B.A. in Accounting and Business Management, with honors, from Reichman University. Mr. Srugo is a certified public accountant in Israel.

Omer Srugo

Liat Sidi

Director

Ms. Sidi has served as a director at Scisparc Ltd. since June 2020. Ms. Sidi has served as the accountant of Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX) since September 2016. In addition, Ms. Sidi additionally provides accounting services for various public and private companies such as: Panaxia israel laboratories ltd, Soho real estate ltd, Pure food ltd and others. Ms. Sidi holds a B.A. degree in Tax, finance and accounting studies from the Ramat Gan College of Accounting.

Liat Sidi

Yehonatan Zalman Vinokur

Director

Mr. Vinokur has served as the Chief Executive Officer and Owner of Danny Zeevi Insurance Agency, LTD. since 2017. In addition, since 2002, Mr. Vinokur has worked as a financial adviser for Topick Finance. Mr. Vinokur has a B.A. in Business Management from The College of Management Academic Studies in Rishon LeTsiyon.

Yehonatan Zalman Vinokur

Oz Adler

Director

Mr. Adler has served as the Chief Financial Officer of SciSparc Ltd. since April 2018, and the Chief Executive Officer of SciSparc, and prior to that, from September 2017, he served as Vice President of Finance at SciSparc. Additionally, Mr. Adler currently serves on the board of directors of Elbit Imaging Ltd (TASE: EMITF.TA, OTC: EMITF), Clearmind Medicine Inc. (CSE: CMND, FSE: CWYO, OTC: CMNDF), Jeff’s Brands Ltd. And Charging Robotics Ltd. Previously, Mr. Adler served as the Chief Financial Officer of Xylo Technologies Ltd. from December 2012 and August 2017. Before this, Mr. Adler worked in the audit department of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, from 2012 to 2017. Mr. Adler is a certified public accountant in Israel and holds a B.A. degree in Accounting and Business Management from The College of Management, Israel.

Oz Adler

Get In touch

Leave us a message

Polyrizon Ltd.

Address: HaTidhar St. 5 Raanana Israel

Mail: info@polyrizon-biotech.com

Skip to content